StonvexLoading…
StonvexStonvexStonvexCore line items from CATY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $53.79M | $52.26M | $43.91M | $42.18M |
Operating Income | $390.20M | $317.54M | $403.58M | $472.54M |
Net Income | $315.12M | $285.98M | $354.12M | $360.64M |
EPS (Diluted) | $4.54 | $3.95 | $4.86 | $4.83 |
Total Assets | $24.23B | $23.05B | $23.08B | $21.95B |
Total Liabilities | $21.30B | $20.21B | $20.34B | $19.47B |
Cash & Equivalents | Not available | Not available | Not available | Not available |
Free Cash Flow OCF − CapEx | $363.66M | $325.52M | $381.34M | $463.97M |
Shares Outstanding | 67.20M | 70.86M | 72.67M | 72.74M |